Similarly, Stavropoulou et al. 2016 underscored the impact of cellular origin on AML aggressiveness and identified EMT-related genes, including ZEB1, associated with poor outcomes in AML patients [117]. The gene discussed is ZEB1; the disease is acute myeloid leukemia.